AstraZeneca to buy rare disease specialist Alexion for $39 billion
Update: 2025-10-11
Description
AstraZeneca is set to buy Alexion Pharmaceuticals for $39 billion. If the deal goes through, it will be AstraZeneca’s largest acquisition ever and the biggest pharmaceutical deal of the year to date.The planned purchase highlights continued interest in rare diseases, which appeal to drug developer....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Item Tile, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
